3rd Quarter - Termination

MS. TAMI WAHL for OSRX, INC.

Firm
Client
Income
—
Expenses
—
Terminated
Sep 30, 2019

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Worked to ensure appropriate implementation of federal regulations and standards by providing background on pharmacy compounding and updates on imminent concerns to include the Memorandum of Understanding (Food, Drug and Cosmetic Act 503A(b)(3)(B)(ii)) and standards under the FDCA 503A(b)(1).

LobbyistCovered position, as disclosed
TAMI WAHL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Worked to ensure appropriate implementation of federal regulations and standards by providing background on pharmacy compounding and updates on imminent concerns to include the Memorandum of Understanding (Food, Drug and Cosmetic Act 503A(b)(3)(B)(ii)) and standards under the FDCA 503A(b)(1).

LobbyistCovered position, as disclosed
TAMI WAHL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.